All In Biotech

Drug Trial Radar · NCT00936390

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer

Last checked: Nov 19, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,538 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,538

Actual

Start

Sep 2009

Primary completion

Oct 3, 2020

Study completion Sep 4, 2025

Sponsor

Lead sponsor
Radiation Therapy Oncology GroupResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI); NRG Oncology
First posted
Jul 10, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells and shrink tumors. Androgens can cause the growth of prostate cancer cells. Androgen-deprivation therapy may lessen the amount of androgens made by the body. It is not yet known whether radiation therapy is more effective with or without androgen-deprivation therapy in treating patients with prostate cancer. PURPOSE: This randomized phase III trial is studying radiation therapy to see how well it works compared with radiation therapy given together with androgen-deprivation therapy in treating patients with prostate cancer.

Conditions

  • Prostate Cancer

Interventions

  • bicalutamideDrug

    Administered orally at a dose of one 50 mg tablet per day, beginning within (before, same day as, or after) 10 days of the date of the first LHRH agonist (antagonist) therapy administration and continuing for a total duration of 6 months.

  • flutamideDrug

    Administered orally at a dose of 250 mg (two 125-mg capsules) three times a day for a total daily dose of 750 mg, beginning within (before, same day as, or after) 10 days of with the date of the first LHRH agonist (antagonist) therapy administration and continuing for a total duration of 6 months.

  • LHRH agonist (antagonist) therapyDrug

    LHRH agonist (antagonist) therapy consists of leuprolide, goserelin, buserelin, triptorelin, or degarelix. The manufacturer's instructions should be followed. The first administration occurs with the start of anti-androgen treatment 8 weeks prior to the start of RT. The total duration of LHRH agonist (antagonist) therapy is 6 months.

  • Dose-Escalated Radiation TherapyRadiation

    External beam radiotherapy (EBRT) as 3D Conformal Radiotherapy (3DCRT) or intensity-modulated radiation therapy (IMRT). Brachytherapy is optional, at the discretion of the treating physician. Patients treated entirely via EBRT receive 79.2 Gy delivered in 1.8 Gy fractions. Patients who receive brachytherapy as a component of their RT receive 45 Gy EBRT in 1.8 Gy fractions. Low-dose brachytherapy boost occurs following the EBRT portion of treatment no more than 4 weeks following its completion.High-dose rate brachytherapy boost is delivered in 2 fractions separated by a minimum time span of 6 hours and the implant(s) may be performed during the EBRT portion of the treatment or within 1 week prior to its initiation or following its completion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Alive (Overall Survival)Time frame: From randomization to last follow-up. Follow-up schedule: end of RT (2nd arm only), then every 3 months for a year, every 4 months for 4 years, then yearly. Maximum follow-up at time of analysis was 10.3 years. Five-year rates reported here.

Locations

518 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama

  • Fairbanks Memorial Hospital

    Fairbanks, Alaska

  • Arizona Center for Cancer Care-Peoria

    Peoria, Arizona

  • Saint Joseph's Hospital and Medical Center

    Phoenix, Arizona

  • 21st Century Oncology-Scottsdale

    Scottsdale, Arizona

  • Mayo Clinic in Arizona

    Scottsdale, Arizona

  • Arizona Oncology Services Foundation

    Scottsdale, Arizona

  • Arizona Oncology Associates-West Orange Grove

    Tucson, Arizona

  • Mercy Cancer Center-Hot Springs

    Hot Springs, Arkansas

  • Sutter Cancer Centers Radiation Oncology Services-Auburn

    Auburn, California

  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California

  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park

    Cameron Park, California

  • Mercy San Juan Medical Center

    Carmichael, California

  • Enloe Medical Center

    Chico, California

  • 21st Century Oncology - El Segundo

    El Segundo, California

  • Fresno Cancer Center

    Fresno, California

  • Saint Agnes Medical Center

    Fresno, California

  • Marin General Hospital

    Greenbrae, California

  • Veterans Administration Long Beach Medical Center

    Long Beach, California

  • Los Angeles County-USC Medical Center

    Los Angeles, California

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California

  • Memorial Medical Center

    Modesto, California

  • Kaiser Permanente Oakland-Broadway

    Oakland, California

  • Kaiser Permanente-Oakland

    Oakland, California

  • Desert Regional Medical Center

    Palm Springs, California

  • Stanford Cancer Institute

    Palo Alto, California

  • Feather River Cancer Center

    Paradise, California

  • Pomona Valley Hospital Medical Center

    Pomona, California

  • Kaiser Permanente-Rancho Cordova Cancer Center

    Rancho Cardova, California

  • Kaiser Permanente-Redwood City

    Redwood City, California

  • Kaiser Permanente-Richmond

    Richmond, California

  • Rohnert Park Cancer Center

    Rohnert Park, California

  • Kaiser Permanente-Roseville

    Roseville, California

  • Sutter Cancer Centers Radiation Oncology Services-Roseville

    Roseville, California

  • The Permanente Medical Group-Roseville Radiation Oncology

    Roseville, California

  • Sutter General Hospital

    Sacramento, California

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California

  • Mercy General Hospital Radiation Oncology Center

    Sacramento, California

  • Kaiser Permanente-South Sacramento

    Sacramento, California

Showing 40 of 518 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.